Monash University researchers alongside key partner Halozyme Therapeutics have reported findings in support of shifting the way anti-cancer
Monash study shows subcutaneous delivery with hyaluronidase may boost effectiveness of cancer immunotherapy
Monash University researchers alongside key partner Halozyme Therapeutics have reported findings in support of shifting the way anti-cancer